Negotiating Drug Prices in the US-Lessons From Europe

JAMA Health Forum. 2022 Dec 2;3(12):e224801. doi: 10.1001/jamahealthforum.2022.4801.

Authors

Kerstin N Vokinger¹, Huseyin Naci²

Affiliations

¹ Institute of Law, University of Zurich, Zurich, Switzerland.
² Department of Health Policy, London School of Economics and Political Science, London, England.

PMID: 36547946
DOI: 10.1001/jamahealthforum.2022.4801

No abstract available

Plain language summary

This Viewpoint describes European drug price negotiation practices and compares them with practices in the US.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Costs*
Europe
Negotiating*